vapes are among the top 3 most effective tools for quitting smoking, according to a new review of the evidence by a team of scientists. Other strategies are Varenicline, a prescription drug sold under brand names such as Chantix and Champix, and Cytisine, a plant-based compound sold as an over-the-counter natural health product in Canada and throughout central and eastern Europe and by prescription in the UK.
According to the authors, these quitting tools work best when combined with behavioral support, such as counseling. Bupropion and nicotine replacement therapy (NRT) are also effective, especially when NRT patches are combined with fast-acting forms such as gum.
“For behavioral support, the evidence is strongest for counseling and programs that reward people for quitting,” senior author Jamie Hartmann-Boyce, assistant professor of health policy and management at the School of Public Health and Health Sciences at the University of Massachusetts Amherst, said in a statement.
The review, published on September 4 in the journal Addiction, was conducted by the non-profit Cochrane Tobacco Addiction Group (CTAG). The abstract of CTAG outlines the main findings of 14 Cochrane reviews published by CTAG between 2021 and 2023.
The latest Cochrane review on vapes for smoking cessation concluded that there is high-quality evidence that nicotine-containing vapes can improve quit rates compared with NRT, and moderate-quality evidence that they can improve quit rates compared with nicotine-free vapes.
The 2023 Cochrane review on smoking cessation medications and vape interventions included all medications licensed for the treatment of smoking cessation anywhere in the world, and vapes with or without nicotine. This review included 319 studies (157,179 participants). The most effective interventions were nicotine vapes, varenicline, and cytosine, all of which had high-quality evidence, followed closely by combined NRT.
According to the latest Cochrane review, vapes are confirmed as one of the top three most effective tools for quitting smoking, which undoubtedly adds new honors to the status of vapes in the field of smoking cessation. In a review of the evidence by a group of scientists, vapes were considered one of the most effective smoking cessation tools along with Varenicline (such as Chantix and Champix) and Cytisine (a plant-based compound).
Studies have shown that vapes are effective in helping people quit smoking, especially vapes containing nicotine can increase the quit rate. This finding provides new options for those seeking support to quit smoking and brings new development opportunities to the vape industry.
As an vape brand, Guutuu vapes can also use this research result to emphasize the effectiveness and importance of its products in the field of smoking cessation. Guutuu can actively support consumers who want to get rid of nicotine dependence by providing high-quality, safe and reliable nicotine-containing vape products.
In addition, combined with behavioral support measures such as counseling and reward programs, the success rate of quitting smoking can be further improved. In this smoking cessation support system, vape companies can work with professional organizations to provide comprehensive smoking cessation plans and provide users with more comprehensive support and guidance.
Overall, based on the latest Cochrane evaluation results, the status of vapes in the field of smoking cessation has been recognized, and vapes are expected to play a greater role in the field of smoking cessation, helping more people achieve their smoking cessation goals and improve their overall health.
Tags: Research on vapes as Quit Aids，Top 3 Most Effective Tools for Quitting Smoking，Guutuu vape